The implications of genetic studies of major mood disorders for clinical practice

Journal of Clinical Psychiatry

Volumn 61, Issue 9, 2000, Pages 630-637

  Duffy, A ^a   Grof, P ^a   Robertson, C ^a   Alda, M ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FLUVOXAMINE MALEATE; LITHIUM; MONOAMINE OXIDASE INHIBITOR; PSYCHOTROPIC AGENT; SEROTONIN TRANSPORTER; TRANYLCYPROMINE; TRICYCLIC ANTIDEPRESSANT AGENT;

AFFECTIVE NEUROSIS; ARTICLE; CLINICAL PRACTICE; COHORT ANALYSIS; DISEASE TRANSMISSION; FAMILY HISTORY; FAMILY STUDY; GENDER; GENETIC COUNSELING; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; INHERITANCE; MANIC DEPRESSIVE PSYCHOSIS; ONSET AGE; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; RISK ASSESSMENT; ADULT; BIPOLAR DISORDER; CHILD; COMORBIDITY; DEPRESSION; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; PEDIGREE; PHARMACOGENETICS; PREVALENCE; PROBABILITY; REVIEW; RISK FACTOR; SEX DIFFERENCE; TREATMENT OUTCOME;

ADULT; AGE OF ONSET; BIPOLAR DISORDER; CHILD; COMORBIDITY; DEPRESSIVE DISORDER; FEMALE; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LITHIUM; MALE; PEDIGREE; PHARMACOGENETICS; PREVALENCE; PROBABILITY; PSYCHOTROPIC DRUGS; RISK FACTORS; SEX FACTORS; TREATMENT OUTCOME;

EID: 0033623241     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v61n0906     Document Type: Article

References (78)

1. Genetics of affective illness
2. Bipolar disorder: From families to genes
3. The genetics of depression and manic-depressive disorder
4. Ascertainment in sequential sampling of pedigrees
5. The family history approach to diagnosis: How useful is it?
6. Cross-national epidemiology of major depression and bipolar disorder
7. Epidemiology of affective disorders: A review
8. Epidemiology of affective disorders: A reexamination and future directions
9. Affective disorders in a US urban community: The use of research diagnostic criteria in an epidemiological survey
10. Affective disorders
11. The emerging epidemiology of hypomania and bipolar II disorder
12. The evolving bipolar spectrum: Prototypes I, II, III, and IV
13. The prevalent clinical spectrum of bipolar disorders: Beyond DSM-IV
14. Zur nosologie endogener depressionen: Vergleich der ergebnisse zweier untersuchungen
15. A family Study of schizoaffective, bipolar I, bipolar II, unipolar and normal control probands
16. A study of bipolar (manic-depressive) and unipolar recurrent depressive psychoses, I: Genetic investigation
17. A genetic study of bipolar affective disorder
18. Transmitted factors in the morbid risk of affective disorders: A controlled study
19. Morbidity risks of schizophrenia and affective disorders among first degree relatives of patients with schizophrenia, mania, depression, and surgical conditions
20. Bipolar manic-depressive psychoses: Results of a genetic investigation
21. Schizoaffective illness, schizophrenia and affective disorders: Morbidity risk and genetic transmission
22. Psychiatric disorders in the relatives of probands with affective disorders
23. A family study of bipolar II disorder
24. Search for biological/genetic markers in a long-term epidemiological and morbid risk study for affective disorders
25. The familial transmission of bipolar illness
26. Unipolar relatives in bipolar pedigrees: Are they bipolar?
27. Assessment of lineality in bipolar I linkage studies
28. Genetics
29. Genetics of affective disorders
30. Major genes for major affective disorder?
31. Onset of major depression in early adulthood
32. Understanding the clinical heterogeneity of major depression using family data
33. A family study of bipolar I disorder in adolescence: Early onset of symptoms linked to increased familial loading and lithium resistance
34. Relevance of early age-of-onset in genetic studies in bipolar affective disorder
35. Family-genetic aspects of juvenile affective disorders
36. Increasing rates of depression
37. Lithium response and genetics of affective disorders
38. Are schizoaffective psychoses heterogeneous? Results of a genetic investigation, II
39. Schizoaffective disorders: Results of a genetic investigation, I
40. Possible role of X-linked dominant factor in manic depressive disease
41. Family history studies, V: The genetics of mania
42. The question of X-linkage in bipolar manic-depressive illness
43. A critical appraisal of X-linked bipolar illness: Evidence for the assumed mode of inheritance is lacking
44. Genetic linkage between X-chromosome markers and bipolar affective illness
45. Evidence of a predisposing locus to bipolar disorder on Xq24-q27.1 in an extended Finnish pedigree
46. Sixth World Congress of Psychiatric Genetics X Chromosome Workshop
47. Evidence for linkage of bipolar disorder to chromosome 18 with a parent-of-origin effect
48. Patterns of maternal transmission in bipolar affective disorder
49. Affective disorders in five United States communities
50. Sex-related differences in depression: Familial evidence
51. Gender differences in bipolar affective disorder
52. Genetic factors in the sex ratio of major depression
53. The impact of phenotypic variation on genetic analysis: Application to X-linkage in manic-depressive illness
54. Contested boundaries of bipolar disorder and the limits of categorical diagnosis in psychiatry
55. Affective disorders in referred children and younger siblings of manic-depressives
56. Bipolar illness in adolescents with major depression
57. Bipolar outcome in the course of depressive illness: Phenomenologic, familial, and pharmacologic predictors
58. Examining the validity of DSM-III-R schizoaffective disorder and its putative subtypes in the Roscommon family study
59. Familial syndrome patterns in schizophrenia, schizoaffective disorder, mania and depression
60. Evidence supporting the independent inheritance of primary affective disorders and primary alcoholism in the families of bipolar patients
61. Who responds to prophylactic lithium therapy?
62. Prediction of response to stabilizing lithium treatment
63. The challenge of predicting response to stabilising lithium treatment
64. Relationship between the effectiveness of lithium therapy and family history
65. Factors associated with treatment success in lithium carbonate prophylaxis: Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group
66. The use of lithium in affective disorders, 3: A double-blind study of prophylaxis in bipolar illness
67. A clinical analysis of the effects of tofranil in depression: Longitudinal and follow-up studies: Treatment of blood-relations
68. Differentiation of two genetically specific types of depression by the response to antidepressant drugs
69. Pharmacogenetic response to antidepressants in a multicase family with affective disorder
70. Familial concordance of fluvoxamine response as a tool for differentiating mood disorder pedigrees
71. Polymorphism within the promoter of the serotonin transporter gene and antidepressant efficacy of fluvoxamine
72. Mode of inheritance in mood disorder families according to fluvoxamine response
73. Pharmacogenetics of lithium response in bipolar disorders
74. Lithium in children of lithium-responding parents
75. Lithium carbonate treatment of select behavior disorders in children suggesting manic-depressive illness
76. Lithium carbonate use in children and adolescents: A survey of the literature
77. Manic-depressive illness in children and effect of treatment with lithium carbonate
78. Psychiatric symptoms and syndromes among adolescent children of parents with lithium-responsive or lithium-nonresponsive bipolar disorder